WHITTLE SURGERY — All Prescriptions & Medications — Page 4
Practice Code: P81143 | CHORLEY, PR6 7PY
Showing results 151-200 of 649
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Vortioxetine | 281 | 7,711 | £7.3K | +304.9% ▲ |
| Methylphenidate hydrochloride | 281 | 9,363 | £7.1K | +8.8% ▲ |
| Flecainide acetate | 274 | 20.5K | £715 | +250.9% ▲ |
| Glyceryl trinitrate | 274 | 624 | £764 | +15.8% ▲ |
| Cyclizine hydrochloride | 274 | 14.7K | £542 | +69.9% ▲ |
| Bisacodyl | 269 | 10.1K | £601 | +105.2% ▲ |
| Estradiol | 266 | 5,728 | £3.3K | -1.4% vs avg |
| Topiramate | 264 | 16.4K | £3.5K | +48.5% ▲ |
| Co-beneldopa (Benserazide/levodopa) | 264 | 38.2K | £2.4K | +74.6% ▲ |
| Pantoprazole | 261 | 11.4K | £522 | -5.1% ▼ |
| Prochlorperazine maleate | 259 | 10.1K | £626 | +28.1% ▲ |
| Betamethasone esters | 259 | 13.3K | £2.2K | +329.3% ▲ |
| Timolol | 256 | 7,015 | £2.0K | +189.4% ▲ |
| Promethazine hydrochloride | 253 | 14.4K | £1.4K | -29.2% ▼ |
| Semaglutide | 253 | 7,475 | £22.0K | +5.1% ▲ |
| Cefalexin | 249 | 14.0K | £745 | +114.1% ▲ |
| Fludrocortisone acetate | 239 | 7,636 | £1.5K | +126.6% ▲ |
| Valsartan | 233 | 8,981 | £2.0K | +295.6% ▲ |
| Lidocaine hydrochloride | 233 | 7,172 | £4.1K | +35.1% ▲ |
| Quinine sulfate | 228 | 6,780 | £927 | -21.2% ▼ |
| Diclofenac diethyl | 220 | 30.1K | £1.8K | -38.0% ▼ |
| 220 | 24.9K | £739 | -20.4% ▼ | |
| Fusidic acid | 219 | 5,160 | £636 | +71.5% ▲ |
| 218 | 1,650 | £703 | +4.3% ▲ | |
| Insulin Lispro | 217 | 1,551 | £10.5K | +183.6% ▲ |
| Calcipotriol | 217 | 15.3K | £8.3K | +27.5% ▲ |
| Enalapril maleate | 215 | 7,700 | £332 | +19.7% ▲ |
| Pravastatin sodium | 213 | 7,560 | £339 | -34.4% ▼ |
| Hyoscine butylbromide | 211 | 23.6K | £1.7K | -9.5% ▼ |
| Beclometasone dipropionate | 211 | 221 | £652 | -1.9% vs avg |
| Terbutaline sulphate | 210 | 1,226 | £2.6K | +287.2% ▲ |
| Carbomer 940/980 | 208 | 4,200 | £793 | +36.6% ▲ |
| Nystatin | 203 | 6,840 | £392 | +101.4% ▲ |
| Insulin degludec | 202 | 1,067 | £10.6K | +83.8% ▲ |
| Tadalafil | 202 | 3,001 | £1.3K | +18.8% ▲ |
| Tolterodine | 200 | 5,705 | £716 | +34.5% ▲ |
| Fluticasone furoate | 200 | 216 | £1.5K | +3.2% ▲ |
| Clobazam | 199 | 14.7K | £3.5K | +201.9% ▲ |
| Sacubitril/valsartan | 198 | 11.0K | £18.0K | -17.3% ▼ |
| Oxybutynin | 198 | 12.2K | £3.2K | +3.9% ▲ |
| Trospium chloride | 198 | 5,344 | £3.2K | +287.8% ▲ |
| Hydroxychloroquine sulfate | 194 | 9,356 | £419 | +0.2% vs avg |
| Fluticasone/umeclidinium/vilanterol | 189 | 233 | £9.9K | -19.4% ▼ |
| 189 | 12.6K | £1.1K | +170.8% ▲ | |
| Ivabradine | 186 | 9,772 | £1.5K | +95.7% ▲ |
| Powder thickener - gum based (0913161) | 186 | 244.3K | £12.4K | +147.7% ▲ |
| Prednisolone | 185 | 4,463 | £485 | +157.1% ▲ |
| 181 | 5,070 | £2.1K | +134.1% ▲ | |
| Clobetasol propionate | 180 | 11.8K | £937 | +31.9% ▲ |
| Pivmecillinam hydrochloride | 177 | 3,706 | £2.0K | +237.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.